by John Conrad | Jun 27, 2024 | Policy News
In a significant move to address longstanding issues of underrepresentation in medical research, the U.S. Food and Drug Administration (FDA) has released a draft guidance document aimed at increasing diversity in clinical trials. This much-anticipated guidance, titled...
by John Conrad | Jun 27, 2024 | NewsBrief
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Epkinly (epcoritamab-bysp), a joint development by AbbVie and Genmab, for the treatment of adults with relapsed or refractory (R/R) follicular lymphoma (FL). This approval specifically...
by John Conrad | Jun 25, 2024 | iBIO News
The Illinois Biotechnology Innovation Organization (iBIO) has kicked off its 2024 STEMgirls Summer Camp, aiming to inspire and educate young girls in science, technology, engineering, and mathematics (STEM). The camp, which began on June 24, 2024, at Cristo Rey St....
by John Conrad | Jun 25, 2024 | NewsBrief
In a significant advancement for heart failure treatment, Endotronix, Inc. has announced FDA Premarket Approval for their Cordella™ Pulmonary Artery (PA) Sensor System. This innovative technology promises to revolutionize the way we manage heart failure patients,...
by John Conrad | Jun 21, 2024 | iBIO News
NewsBrief Weekly News Quiz: June 21 Biotech Buzz: Weekly Knowledge Challenge Attention biotech enthusiasts! This quiz is your chance to test your grasp of recent developments in the life sciences. How well do you know the latest life sciences news? Let’s find...
